CDEK
← All organizations

NBE-Therapeutics AG

For profitWebsite ↗

Also known as: NBE-Therapeutics AG

Phase 1Phase 2Phase 3Phase 4

Highest phase reached

Phase 2

First clinical trial

Jun 19, 2020

Last known activity

Jun 19, 2020

Acquired by Boehringer Ingelheim on Dec 17, 2021

Timeline

2010s

  1. Jun 1, 2012

    NBE-Therapeutics AG— Founded

2020s

  1. Dec 17, 2021

    Boehringer Ingelheim— Acquired By

Drugs by trial phase (1 distinct, 1 trials)

Phase 2 (1 own, 0 via acquisition)

Indications

Studied for

Recent trials (1)

Details

Founded
Basel, CH Jun 1, 2012
Last known activity
Jun 19, 2020